BioInvent

A quarter of billion-euro licences, a Novo comeback and a flat Nordic index – the State of Nordic BioPharma | 2026:Q3

BioInvent International | Investing in Life Science 2026

CSO Björn Frendéus presents BioInvent International at Investing...

AstraZeneca fires three barrels, Implantica enters the US – the Nordic Pulse | 2026:34

Novo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31

Lilly calls on AlzeCure, Novo Nordisk pops a pill – the Nordic Pulse | 2026:24

Starka kliniska framsteg i fokus under BioInvents KOL-event

Under torsdagen arrangerade Bioinvent sitt andra KOL-event på...

Lundbeck breaks through, Sectra breaks records – The Nordic Pulse | 2026:23

Hansa shines, Elekta stumbles, biotech bounces – the Nordic Pulse | 2026:22

BioInvent International | Global Forum 2026

CSO Björn Frendeus presents BioInvent International at Global...

BioInvent erhåller milstolpsbetalning efter studiestart med HMI-115

BioInvent har erhållit en milstolpsbetalning om 1 miljon...

BioInvent tar sats mot fler milstolpar under 2026

BioInvent presenterade i dag sin bokslutskommuniké för 2025,...